ENTX (STOCKS)
Entera Bio Ltd. Ordinary Shares
$1.210000
-0.020000 (-1.63%)
Prev close: $1.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Miranda J. Toledano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $58.69M
- Employees
- 21
- P/E (TTM)
- -4.59
- P/B (TTM)
- 5.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.07 | $-0.15 | +0.0830 | +54.25% |
|
Dec 2025 (Q4)
|
$-0.07 | $-0.09 | +0.0218 | +23.75% |
|
Sep 2025 (Q3)
|
$-0.07 | $-0.09 | +0.0218 | +23.75% |
|
Jun 2025 (Q2)
|
$-0.06 | $-0.11 | +0.0522 | +46.52% |
Financial Statements
| Revenues | $0.00 |
| Cost Of Revenue | $0.00 |
| Gross Profit | $0.00 |
| Nonoperating Income/Loss | $128.00K |
| Operating Expenses | $12.51M |
| Selling, General, and Administrative Expenses | $407.00K |
| Research and Development | $7.13M |
| Other Operating Expenses | $4.97M |
| Operating Income/Loss | -$12.51M |
| Income/Loss From Continuing Operations After Tax | -$12.38M |
| Income/Loss From Continuing Operations Before Tax | -$20.84M |
| Net Income/Loss | -$12.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.27 |
| Diluted Earnings Per Share | $0.27 |
| Basic Average Shares | 142,044,489 |
| Diluted Average Shares | 142,044,489 |
| Assets | $13.13M |
| Current Assets | $12.49M |
| Prepaid Expenses | $310.00K |
| Other Current Assets | $12.18M |
| Noncurrent Assets | $636.00K |
| Fixed Assets | $127.00K |
| Other Non-current Assets | $509.00K |
| Liabilities | $2.44M |
| Current Liabilities | $1.58M |
| Accounts Payable | $274.00K |
| Other Current Liabilities | $1.30M |
| Noncurrent Liabilities | $866.00K |
| Equity | $10.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.69M |
| Liabilities And Equity | $13.13M |
| Net Cash Flow From Operating Activities | -$9.06M |
| Net Cash Flow From Operating Activities, Continuing | -$9.06M |
| Net Cash Flow From Investing Activities | $2.86M |
| Net Cash Flow From Investing Activities, Continuing | $2.86M |
| Net Cash Flow From Financing Activities | $503.00K |
| Net Cash Flow From Financing Activities, Continuing | $503.00K |
| Exchange Gains/Losses | -$32.00K |
| Net Cash Flow | -$5.73M |
| Net Cash Flow, Continuing | -$5.70M |
| Comprehensive Income/Loss | -$12.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.38M |
| Other Comprehensive Income/Loss | $0.00 |